115 related articles for article (PubMed ID: 9661892)
21. Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo.
Al-Khaldi A; Eliopoulos N; Martineau D; Lejeune L; Lachapelle K; Galipeau J
Gene Ther; 2003 Apr; 10(8):621-9. PubMed ID: 12692590
[TBL] [Abstract][Full Text] [Related]
22. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
Wood JM
Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930
[TBL] [Abstract][Full Text] [Related]
24. Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma.
Yoshiji H; Kuriyama S; Yoshii J; Ikenaka Y; Noguchi R; Hicklin DJ; Huber J; Nakatani T; Tsujinoue H; Yanase K; Imazu H; Fukui H
Hepatology; 2002 Apr; 35(4):834-42. PubMed ID: 11915029
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of angiogenesis by humulone, a bitter acid from beer hop.
Shimamura M; Hazato T; Ashino H; Yamamoto Y; Iwasaki E; Tobe H; Yamamoto K; Yamamoto S
Biochem Biophys Res Commun; 2001 Nov; 289(1):220-4. PubMed ID: 11708802
[TBL] [Abstract][Full Text] [Related]
26. VEGF spatially directs angiogenesis during metanephric development in vitro.
Tufró A
Dev Biol; 2000 Nov; 227(2):558-66. PubMed ID: 11071774
[TBL] [Abstract][Full Text] [Related]
27. Suppression of tumor angiogenesis and growth by gene transfer of a soluble form of vascular endothelial growth factor receptor into a remote organ.
Takayama K; Ueno H; Nakanishi Y; Sakamoto T; Inoue K; Shimizu K; Oohashi H; Hara N
Cancer Res; 2000 Apr; 60(8):2169-77. PubMed ID: 10786681
[TBL] [Abstract][Full Text] [Related]
28. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth.
Duh EJ; Yang HS; Suzuma I; Miyagi M; Youngman E; Mori K; Katai M; Yan L; Suzuma K; West K; Davarya S; Tong P; Gehlbach P; Pearlman J; Crabb JW; Aiello LP; Campochiaro PA; Zack DJ
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):821-9. PubMed ID: 11867604
[TBL] [Abstract][Full Text] [Related]
29. The C-terminal domain of canstatin suppresses in vivo tumor growth associated with proliferation of endothelial cells.
He GA; Luo JX; Zhang TY; Hu ZS; Wang FY
Biochem Biophys Res Commun; 2004 May; 318(2):354-60. PubMed ID: 15120609
[TBL] [Abstract][Full Text] [Related]
30. Effect of flavone acetic acid on endothelial cell proliferation: evidence for antiangiogenic properties.
Lindsay CK; Gomez DE; Thorgeirsson UP
Anticancer Res; 1996; 16(1):425-31. PubMed ID: 8615648
[TBL] [Abstract][Full Text] [Related]
31. The heparan sulfate suleparoide inhibits rat corneal angiogenesis and in vitro neovascularization.
Benelli U; Bocci G; Danesi R; Lepri A; Bernardini N; Bianchi F; Lupetti M; Dolfi A; Campagni A; Agen C; Nardi M; Del Tacca M
Exp Eye Res; 1998 Aug; 67(2):133-42. PubMed ID: 9733580
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of pathological corneal neovascularization by a small peptide derived from human apolipoprotein (a) Kringle V.
Wang Z; Zhao H; Ma JX; Xu X
Cornea; 2014 Apr; 33(4):405-13. PubMed ID: 24452210
[TBL] [Abstract][Full Text] [Related]
34. Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes.
Bråkenhielm E; Cao R; Cao Y
FASEB J; 2001 Aug; 15(10):1798-800. PubMed ID: 11481234
[No Abstract] [Full Text] [Related]
35. Inhibition of angiogenesis and tumor growth by a synthetic laminin peptide, CDPGYIGSR-NH2.
Sakamoto N; Iwahana M; Tanaka NG; Osada Y
Cancer Res; 1991 Feb; 51(3):903-6. PubMed ID: 1703042
[TBL] [Abstract][Full Text] [Related]
36. Murine epidermal growth factor (EGF) fragment (33-42) inhibits both EGF- and laminin-dependent endothelial cell motility and angiogenesis.
Nelson J; Allen WE; Scott WN; Bailie JR; Walker B; McFerran NV; Wilson DJ
Cancer Res; 1995 Sep; 55(17):3772-6. PubMed ID: 7543818
[TBL] [Abstract][Full Text] [Related]
37. Isolation and characterization of human tumor-derived capillary endothelial cells: role of oncofetal fibronectin.
Alessandri G; Chirivi RG; Castellani P; Nicoló G; Giavazzi R; Zardi L
Lab Invest; 1998 Jan; 78(1):127-8. PubMed ID: 9461129
[No Abstract] [Full Text] [Related]
38. Inhibition of angiogenesis by thrombospondin-2.
Volpert OV; Tolsma SS; Pellerin S; Feige JJ; Chen H; Mosher DF; Bouck N
Biochem Biophys Res Commun; 1995 Dec; 217(1):326-32. PubMed ID: 8526929
[TBL] [Abstract][Full Text] [Related]
39. Cytochalasin E, an epoxide containing Aspergillus-derived fungal metabolite, inhibits angiogenesis and tumor growth.
Udagawa T; Yuan J; Panigrahy D; Chang YH; Shah J; D'Amato RJ
J Pharmacol Exp Ther; 2000 Aug; 294(2):421-7. PubMed ID: 10900214
[TBL] [Abstract][Full Text] [Related]
40. Angiogenesis is stimulated by a tumor-derived endothelial cell growth factor.
Shing Y; Folkman J; Haudenschild C; Lund D; Crum R; Klagsbrun M
J Cell Biochem; 1985; 29(4):275-87. PubMed ID: 2418039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
